North America Dry Eye Syndrome Treatment Market Size & Outlook
North America dry eye syndrome treatment market, 2018-2030 (US$M)
Related Markets
North America dry eye syndrome treatment market highlights
- The North America dry eye syndrome treatment market generated a revenue of USD 2,324.4 million in 2022.
- The market is expected to grow at a CAGR of 7.6% from 2023 to 2030.
- In terms of segment, evaporative dry eye syndrome was the largest revenue generating type in 2022.
- Evaporative Dry Eye Syndrome is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 2,324.4 million |
| Market revenue in 2030 | USD 4,174.0 million |
| Growth rate | 7.6% (CAGR from 2022 to 2030) |
| Largest segment | Evaporative dry eye syndrome |
| Fastest growing segment | Evaporative Dry Eye Syndrome |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
| Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
Other key industry trends
- In terms of revenue, North America region accounted for 42.0% of the global dry eye syndrome treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,715.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dry Eye Syndrome Treatment Market Scope
Dry Eye Syndrome Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America dry eye syndrome treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.49% in 2022. Horizon Databook has segmented the North America dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest share of 42.01% of dry eye syndrome treatment market in 2022 owing to factors such as the rising prevalence of eye diseases and favorable government initiatives in the region. North America is a developed region with high healthcare expenditure. The local presence of regulatory entities in North American countries is expected to boost the development of dry eye treatment drugs in the near future.
This is mainly because these entities play a pivotal role in creating awareness among people about the potential of dry eye treatment therapies in disease management. Moreover, the high prevalence and increasing eye treatment procedures aid expansion in North America. High healthcare costs are among the primary factors driving market growth and boosting the demand for fast-acting and high-efficacy drugs.
A growing emphasis on personalized medicine, increasing collaborations & externalizations with academic research institutes, and rapid adoption of healthcare IT are some of the other factors anticipated to further propel the market growth in the region. Furthermore, increasing awareness about high-potency drugs, rising demand for dry eye treatment therapeutics, and a growing number of biotechnology companies are contributing to the region’s leading market share.
Reasons to subscribe to North America dry eye syndrome treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America dry eye syndrome treatment market databook
-
Our clientele includes a mix of dry eye syndrome treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dry eye syndrome treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America dry eye syndrome treatment market size, by country, 2018-2030 (US$M)
North America Dry Eye Syndrome Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
